BioHarvest Sciences (NASDAQ:BHST) Trading Down 1.1% – Here’s What Happened

BioHarvest Sciences Inc. (NASDAQ:BHST)’s share price was down 1.1% on Thursday . The company traded as low as $4.65 and last traded at $4.65. Approximately 18,552 shares were traded during mid-day trading, a decline of 51% from the average daily volume of 37,636 shares. The stock had previously closed at $4.70.

Analyst Ratings Changes

Several analysts recently weighed in on BHST shares. Weiss Ratings restated a “sell (d-)” rating on shares of BioHarvest Sciences in a research note on Monday, December 29th. Wall Street Zen raised shares of BioHarvest Sciences to a “hold” rating in a research report on Saturday, October 18th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $14.50.

BioHarvest Sciences Trading Up 3.0%

The stock’s fifty day moving average price is $5.34 and its two-hundred day moving average price is $7.62. The stock has a market capitalization of $78.65 million, a P/E ratio of -7.04 and a beta of 1.12. The company has a current ratio of 1.35, a quick ratio of 1.02 and a debt-to-equity ratio of 0.30.

BioHarvest Sciences (NASDAQ:BHST) last posted its earnings results on Thursday, November 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). The company had revenue of $9.07 million for the quarter, compared to analysts’ expectations of $9.11 million. BioHarvest Sciences had a negative return on equity of 1,041.86% and a negative net margin of 36.33%. Equities research analysts forecast that BioHarvest Sciences Inc. will post -0.8 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in BioHarvest Sciences stock. True North Advisors LLC raised its holdings in shares of BioHarvest Sciences Inc. (NASDAQ:BHST) by 676.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 168,013 shares of the company’s stock after purchasing an additional 146,365 shares during the quarter. True North Advisors LLC owned 1.02% of BioHarvest Sciences worth $1,581,000 as of its most recent filing with the Securities & Exchange Commission.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.